FrancophonIA/ELRC3.0 huggingface dataset:
English: Do not use in cases of hypersensitivity to any of the active substances or to any of the excipients.
Croatian: Ne primjenjivati u slučajevima preosjetljivosti na bilo koju djelatnu tvar ili na bilo koju od pomoćnih tvari.
English: This veterinary medicine kills and repels ticks (Rhipicephalus sanguineus and Ixodes ricinus ticks are controlled for one month; Dermacentor reticulatus ticks are controlled for up to three weeks).
Croatian: Ovaj veterinarsko-medicinski proizvod ubija i odbija krpelje (Rhipicephalus sanguineus i Ixodes ricinus tijekom mjesec dana; Dermacentor reticulatus do tri tjedna).
English: Applicator to be used for dogs 1.5-4 kg
Croatian: Aplikator koji se koristi za pse 1,5 - 4 kg žuta
English: The veterinary medicinal product has persistent acaricidal and repellent efficacy against tick infestations (Rhipicephalus sanguineus and Ixodes ricinus for one month, and Dermacentor reticulatus for up to three weeks).
Croatian: Krpelji: Veterinarsko-medicinski proizvod ima perzistetntnu akaricidnu i repelentnu aktivnost protiv infestacije krpeljima (Rhipicephalus sanguineus i Ixodes ricinus tijekom mjesec dana i Dermacentor reticulatus do tri tjedna).
English: This veterinary medicine should not enter water courses as it is dangerous for fish and other aquatic organisms.
Croatian: Ovaj veterinarsko-medicinski proizvod ne smije se odlagati u otvorene vode jer je opasan za ribe i druge vodene organizme.
English: The veterinary medicinal product should not enter water courses as it is dangerous for fish and other aquatic organisms.
Croatian: Veterinarsko-medicinski proizvod ne smije se odlagati u otvorene vode jer je opasan za ribe i druge vodene organizme.
English: Repels (prevents biting) flying insects such as sand flies, mosquitoes and stable flies for 1 month.
Croatian: Odbija (sprječava ugrize) letećih insekata kao što su papatači, komarci i stajske muhe kroz mjesec dana.
English: Vectra 3D for dogs > 40 kg
Croatian: Vectra 3D za pse > 40 kg
English: Flea insecticide activity starts within 12 hours after application.
Croatian: Ugibanje buha počinje unutar 12 sati nakon aplikacije veterinarsko-medicinskog proizvoda.
English: The veterinary medicine repels (prevents biting) flying insects such as sand flies (Phlebotomus perniciosus), mosquitoes (Culex pipiens, Aedes aegypti) and stable flies (Stomoxys calcitrans) for one month after use.
Croatian: Papatači, komarci i stajske muhe Veterinarsko-medicinski proizvod odbija (sprječava ugrize) kukce poput papatača (Phlebotomus perniciosus), komaraca (Culex pipiens, Aedes aegypti) i stajskih muha (Stomoxys calcitrans) tijekom mjesec dana nakon upotrebe.
English: • If the veterinary medicinal product accidentally gets into the eyes, they should be thoroughly flushed with water.
Croatian: • U slučaju da nehotice dospije u oči, temeljito ih isperite s vodom.
English: DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION Spot-on use.
Croatian: DOZIRANJE ZA SVAKU CILJNU VRSTU ŽIVOTINJA, NAČIN I PUT(EVI) PRIMJENE
English: PHARMACEUTICAL FORM Spot-on solution
Croatian: OBLIK Otopina za nakapavanje
English: A synergistic effect was observed in vitro when dinotefuran was administered in conjunction with permethrin, leading to a faster onset of insecticidal activity in vivo.
Croatian: Sinergistički učinak kombinacije dinotefurana s permetrinom uočen in vitro, uzrokuje brži nastup insekticidne aktivnosti in vivo.
English: Pharmacotherapeutic group: Ectoparasiticides, insecticides and repellents, permethrin combinations.
Croatian: Farmakoterapijska grupa: EKTOPARAZITICIDI, insekticidi i repelenti, u kombinaciji s permetrinom ATCvet kod: QP53AC54
English: It prevents biting from sand flies (Phlebotomus perniciosus), mosquitoes (Culex pipiens, Aedes aegypti) and from stable flies (Stomoxys calcitrans) for one month post-application.
Croatian: (Phlebotomus perniciosus), komaraca (Culex pipiens, Aedes aegypti) i stajskih muha (Stomoxys calcitrans) tijekom mjesec dana nakon primjene.
English: Dogs over 40 kg body weight
Croatian: Psi tjelesne težine preko 40 kg
English: ROUTE(S) OF ADMINISTRATION Spot-on use
Croatian: PUT(EVI) PRIMJENE Nakapavanjem
English: Dogs from 1.5 to 4 kg body weight
Croatian: Psi tjelesne težine od 1,5 do 4 kg
English: 4.9 Amounts to be administered and administration route Dosage:
Croatian: 4.9 Količine koje se primjenjuju i put primjene
English: Ticks:
Croatian: Buhe:
English: PHARMACEUTICAL FORM Spot-on solution.
Croatian: OBLIK Otopina za nakapavanje.
English: 4b recommendation: Regardless of the dog's body weight, using the applicator tip, part the hair at the base of the tail and begin applying the veterinary medicinal product directly onto the skin in a continuous line from the base of the tail along the centre of the back all the way up to the shoulder blades, as shown in the diagram, squeezing the applicator until it is empty.
Croatian: Preporuka 4b: Neovisno o tjelesnoj težini psa, vrhom aplikatora razdvojite dlaku na bazi repa i počnite nanositi veterinarsko-medicinski proizvod izravno na kožu u neprekidnoj liniji od baze repa, cijelom duljinom središnje linije leđa, sve do vrhova lopatica, kako je prikazano na slici, stišćući aplikator dok se ne isprazni.
English: If in eyes, immediately flush with water.
Croatian: U slučaju da VMP dospije u kontakt s očima odmah ih isperite vodom.
English: On the day of first treatment this veterinary medicinal product results in adequate flea adulticidal activity within 12 hours after application.
Croatian: Prvi dan tretmana, unutar 12 sati nakon aplikacije veterinarskomedicinskog proizvoda, dolazi do ugibanja odraslih jedinki buha.
English: Vectra 3D spot-on (1.5-4 kg) Vectra 3D spot-on (> 4-10 kg) Vectra 3D spot-on (> 10-25 kg) Vectra 3D spot-on (> 25-40 kg) Vectra 3D spot-on (> 40 kg)
Croatian: Vectra 3D za nakapavanje (1,5 - 4 kg) Vectra 3D za nakapavanje (> 4 - 10 kg) Vectra 3D za nakapavanje (> 10 - 25 kg) Vectra 3D za nakapavanje (> 25 - 40 kg) Vectra 3D za nakapavanje (> 40 kg)
English: 33500 Libourne, FRANCE
Croatian: Ceva Santé Animale 10, av. de La Ballastière 33500 Libourne Francuska
English: This veterinary medicinal product can induce convulsions in cats that could be fatal, due to the unique physiology of this species which is unable to metabolise certain compounds, including permethrin.
Croatian: U mačaka, koje zbog jedinstvene fiziologije ne mogu metabolizirati neke komponente, uključujući i permetrin, ovaj veterinarsko-medicinski proizvod može izazvati konvulzije koje mogu biti fatalne.
English: Fleas:
Croatian: Krpelji:
English: Teal
Croatian: KARENCIJA
English: Pale yellow solution.
Croatian: Blijedožuta otopina.
English: To avoid adverse reactions:
Croatian: Kako bi izbjegli nuspojave pridržavajte se sljedećeg:
English: Vectra 3D for dogs > 10-25 kg for dogs > 25-40 kg Purple
Croatian: Vectra 3D za pse > 10 - 25 kg za pse > 25 - 40 kg ljubičasta
English: Children should avoid contact with the dog during 4 hours after treatment.
Croatian: Djeca ne smiju dirati pse najmanje 4 sata nakon primjene veterinarsko-medicinskog proizvoda.
English: Vectra 3D for dogs 1.5-4 kg for dogs > 4-10 kg
Croatian: Vectra 3D za pse 1,5 - 4 kg za pse > 4 - 10 kg tirkizna
English: N-octyl-2-pyrrolidone
Croatian: Ctenocephalides felis.
English: Vectra 3D spot-on solution for dogs 1.5-4 kg Vectra 3D spot-on solution for dogs > 4-10 kg Vectra 3D spot-on solution for dogs > 10-25 kg Vectra 3D spot-on solution for dogs > 25-40 kg Vectra 3D spot-on solution for dogs > 40 kg dinotefuran / pyriproxyfen / permethrin
Croatian: Vectra 3D otopina za nakapavanje za pse 1,5 - 4 kg Vectra 3D otopina za nakapavanje za pse > 4 - 10 kg Vectra 3D otopina za nakapavanje za pse > 10 - 25 kg Vectra 3D otopina za nakapavanje za pse > 25 - 40 kg Vectra 3D otopina za nakapavanje za pse > 40 kg dinotefuran / piriproksifen / permetrin
English: Red
Croatian: NUSPOJAVE
English: for dogs > 4-10 kg
Croatian: Psi tjelesne težine između 4 i 10 kg
English: 4a recommendation: Gently squeeze the applicator and apply the veterinary medicinal product to the skin along the dog's back, beginning between the shoulder blades, in the number of spots and order shown in the diagrams below and squeezing until the applicator is empty.
Croatian: Preporuka 4a: Lagano stisnite aplikator i nanesite veterinarsko-medicinski proizvod na kožu leđa psa, na jedno ili više mjesta, prema prikazu na slici u nastavku, počevši od vrhova psećih lopatica te stišćite aplikator sve dok se ne isprazni.
English: Vectra 3D for dogs > 4-10 kg for dogs > 10-25 kg
Croatian: Vectra 3D za pse > 4 - 10 kg za pse > 10 - 25 kg plava
English: Vectra 3D for dogs > 25-40 kg for dogs > 40 kg
Croatian: Vectra 3D za pse težine > 25 - 40 kg za pse > 40 kg crvena
English: PACKAGE LEAFLET: Vectra 3D spot-on solution for dogs 1.5-4 kg Vectra 3D spot-on solution for dogs > 4-10 kg Vectra 3D spot-on solution for dogs > 10-25 kg Vectra 3D spot-on solution for dogs > 25-40 kg Vectra 3D spot-on solution for dogs > 40 kg
Croatian: UPUTA O VMP: Vectra 3D otopina za nakapavanje za pse 1,5 - 4 kg Vectra 3D otopina za nakapavanje za pse > 4 - 10 kg Vectra 3D otopina za nakapavanje za pse > 10 - 25 kg Vectra 3D otopina za nakapavanje za pse > 25 - 40 kg Vectra 3D otopina za nakapavanje za pse > 40 kg
English: See package leaflet for instructions for use.
Croatian: Pročitati uputu o VMP za pravilnu primjenu.
English: Vectra 3D spot-on solution for dogs 1.5-4 kg Vectra 3D spot-on solution for dogs > 4-10 kg Vectra 3D spot-on solution for dogs > 10-25 kg Vectra 3D spot-on solution for dogs > 25-40 kg Vectra 3D spot-on solution for dogs > 40 kg
Croatian: Vectra 3D otopina za nakapavanje za pse 1,5 - 4 kg Vectra 3D otopina za nakapavanje za pse > 4 - 10 kg Vectra 3D otopina za nakapavanje za pse > 10 - 25 kg Vectra 3D otopina za nakapavanje za pse > 25 - 40 kg Vectra 3D otopina za nakapavanje za pse teže od > 40 kg
English: The treatment provides persistent repellent (anti-feeding) activity.
Croatian: Papatači, komarci i stajske muhe: Tretman osigurava perzistentnu repelentnu aktivnost (sprječava hranjenje).
English: Spot-on use.
Croatian: Nakapavanjem.
English: METHOD AND ROUTE(S) OF ADMINISTRATION Spot-on use for external application to the skin.
Croatian: Za vanjsku primjenu nakapavanjem, na kožu.
English: The full EPAR for Ozempic can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Ozempic nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: If needed, the dose can be further increased up to a maximum of 1 mg once a week.
Croatian: Doza se prema potrebi može dalje povećavati do najviše 1 mg jednom tjedno.
English: After four weeks, this dose should be increased to 0.5 mg.
Croatian: Nakon četiri tjedna tu je dozu potrebno povećati na 0,5 mg.
English: Ozempic semaglutide
Croatian: Ozempic semaglutid
English: Regarding safety, this was considered in line with that of other medicines of the same class.
Croatian: S obzirom na sigurnost, ona se smatra podudarnom sa sigurnošću primjene drugih lijekova iz iste skupine.
English: What measures are being taken to ensure the safe and effective use of Ozempic?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Ozempic?
English: Other information about Ozempic
Croatian: Ostale informacije o lijeku Ozempic
English: Worsening of diabetic retinopathy has also been observed and will be further investigated.
Croatian: Također je opaženo pogoršanje dijabetičke retinopatije, što će se dodatno istraživati.
English: What is Ozempic and what is it used for?
Croatian: Što je Ozempic i za što se koristi?
English: It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food.
Croatian: Djeluje na isti način kao i GLP-1 (hormon koji se proizvodi u crijevima) tako što povećava količinu inzulina koji se oslobađa u gušterači kao odgovor na unos hrane.
English: It can also be used as an ‘add-on' to other diabetes medicines.
Croatian: Može se također primjenjivati kao dodatak drugim lijekovima protiv šećerne bolesti.
English: This is a summary of the European public assessment report (EPAR) for Ozempic.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Ozempic.
English: Serious worsening of diabetic retinopathy (damage to the retina, the light sensitive membrane at the back of the eye) is common (it may affect up to 1 in 10 people).
Croatian: Česta su ozbiljna pogoršanja dijabetičke retinopatije (oštećenje retine, opne osjetljive na svjetlo koja se nalazi u stražnjem dijelu oka) (mogu se pojaviti u do 1 na 10 osoba).
English: The starting dose of Ozempic is 0.25 mg once a week.
Croatian: Početna je doza lijeka Ozempic 0,25 mg jednom tjedno.
English: Ozempic can be used on its own in patients who cannot take metformin (another diabetes medicine).
Croatian: Ozempic se može primjenjivati kao jedini lijek u bolesnika koji ne mogu uzimati metformin (drugi lijek protiv šećerne bolesti).
English: When looking at the three ‘events' separately, fewer patients taking Ozempic had a heart attack or stroke, but rates of death from heart problems were similar in the two groups.
Croatian: Promatrajući ta tri „događaja” odvojeno, manje je bolesnika koji su uzimali lijek Ozempic imalo srčani ili moždani udar, dok su stope smrtnih ishoda zbog tegoba sa srcem bile slične u obje skupine.
English: Five studies in over 4,000 patients showed that Ozempic lowered levels of HbA1c (a measure of blood glucose) by between 1.2 and 1.8 percentage points over 10 to 13 months.
Croatian: Pet ispitivanja provedenih u više od 4 000 bolesnika pokazalo je da je lijek Ozempic snizio razine HbA1c (pokazatelj glukoze u krvi) između 1,2 i 1,8 postotnih bodova tijekom 10 do 13 mjeseci.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ozempic have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Ozempic nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: What are the risks associated with Ozempic?
Croatian: Koji su rizici povezani s lijekom Ozempic?
English: These are mild or moderate in severity and of short duration.
Croatian: Nuspojave su blage ili umjerene i ne traju dugo.
English: The European Medicines Agency concluded that the benefits of Ozempic seen in studies outweighed its risk and recommended it be approved for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi lijeka Ozempic opažene u ispitivanjima nadmašuju s njim povezane rizike te je preporučila njegovo odobrenje za primjenu u Europskoj uniji.
English: The active substance in Ozempic, semaglutide, is a ‘GLP-1 receptor agonist'.
Croatian: Djelatna tvar lijeka Ozempic, semaglutid, agonist je receptora GLP-1.
English: Ozempic in these studies compared favourably with other treatments, sitagliptin, exenatide and insulin glargine (which led to reductions of 0.55, 0.92, 0.83 percentage points respectively) and placebo (reductions of up to 0.09 percentage points).
Croatian: Ta ispitivanja pokazala su prednost lijeka Ozempic u usporedbi s drugim terapijama, sitagliptinom, eksenatidom i inzulin glarginom (koji su doveli do smanjenja od 0,55 postotnih bodova, 0,92 odnosno 0,83 postotna boda) i placebom (smanjenja do 0,09 postotnih bodova).
English: Ozempic was also shown to be effective at reducing the occurrence of serious health complications associated with diabetes such as heart attack and stroke.
Croatian: Lijek Ozempic također se pokazao učinkovitim u smanjenju pojave ozbiljnih zdravstvenih komplikacija povezanih sa šećernom bolešću, kao što su srčani udar i moždani udar.
English: Why is Ozempic approved?
Croatian: Zašto je lijek Ozempic odobren?
English: Ozempic is a diabetes medicine used with diet and exercise to treat adults whose type 2 diabetes is not satisfactorily controlled.
Croatian: Ozempic je lijek protiv šećerne bolesti koji se uz dijetalnu prehranu i tjelovježbu koristi za liječenje odraslih osoba u kojih šećerna bolest tipa 2 nije pod odgovarajućom kontrolom.
English: A further study in over 3,000 diabetes patients at high risk of heart problems showed that overall, heart attack, stroke or death occurred less frequently in patients treated with Ozempic (6.6%) than with placebo (8.9%).
Croatian: Dodatno ispitivanje provedeno u više od 3 000 bolesnika sa šećernom bolešću i visokim rizikom od srčanih tegoba pokazalo je sveukupno manju učestalost srčanog udara, moždanog udara ili smrtnog ishoda u bolesnika liječenih lijekom Ozempic (6,6 %) u usporedbi s placebom (8,9 %).
English: The most common side effects with Ozempic (which may affect more than 1 in 10 people) include problems with the digestive system, such as diarrhoea, vomiting and nausea (feeling sick).
Croatian: Najčešće nuspojave lijeka Ozempic (koje se mogu pojaviti u više od 1 na 10 osoba) uključuju tegobe s probavnim sustavom, kao što su proljev i mučnina.
English: Studies showed that Ozempic is effective at lowering blood glucose levels and reducing the risk of health complications in patients with type 2 diabetes.
Croatian: Ispitivanja su pokazala da Ozempic učinkovito snižava razine glukoze u krvi i smanjuje rizik od zdravstvenih komplikacija u bolesnika sa šećernom bolešću tipa 2.
English: It is not intended to provide practical advice on how to use Ozempic.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Ozempic.
English: In addition, the results indicated that treatment with Ozempic was associated with a beneficial fall in body weight.
Croatian: Nadalje, rezultati su pokazali da je terapija lijekom Ozempic bila povezana s korisnim smanjenjem tjelesne težine.
English: Ozempic contains the active substance semaglutide.
Croatian: Ozempic sadrži djelatnu tvar semaglutid.
English: Treatment with Ozempic also led to weight loss, which is considered beneficial in patients with diabetes.
Croatian: Terapija lijekom Ozempic dovela je i do gubitka težine, što se smatra korisnim u bolesnika sa šećernom bolešću.
English: It is injected under the skin of the belly, the thigh or the upper arm.
Croatian: Ubrizgava se pod kožu abdomena, bedra ili nadlaktice.
English: Ozempic is available as a solution for injection in prefilled pens and can only be obtained with a prescription.
Croatian: Lijek Ozempic dostupan je kao otopina za injekciju u napunjenoj brizgalici, a izdaje se samo na liječnički recept.
English: Side effects affecting the digestive system are considered to be manageable.
Croatian: Smatra se da je nuspojave koje zahvaćaju probavni sustav moguće kontrolirati.
English: For practical information about using Ozempic, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o primjeni lijeka Ozempic bolesnici trebaju pročitati u uputi o lijeku, odnosno trebaju se obratiti svojem liječniku ili ljekarniku.
English: How does Ozempic work?
Croatian: Kako djeluje Ozempic?
English: For more information about treatment with Ozempic, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Ozempic pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svojem liječniku ili ljekarniku.
English: Ozempic was shown to be effective at controlling blood glucose levels.
Croatian: Pokazalo se da Ozempic učinkovito kontrolira razine glukoze u krvi.
English: How is Ozempic used?
Croatian: Kako se Ozempic koristi?
English: For the full list of all side effects and restrictions with Ozempic, see the package leaflet.
Croatian: Potpuni popis svih nuspojava i ograničenja zabilježenih pri primjeni lijeka Ozempic potražite u uputi o lijeku.
English: What benefits of Ozempic have been shown in studies?
Croatian: Koje su koristi lijeka Ozempic utvrđene u ispitivanjima?
English: 1 dose (1 ml) contains: Hepatitis A virus (inactivated)1,2
Croatian: 1 doza (1 ml) sadrži: inaktivirani virus hepatitisa
English: 1Produced on human diploid (MRC-5) cells 2Adsorbed on aluminium hydroxide, hydrated
Croatian: 20 mikrograma proizveden na humanim diploidnim (MRC-5) stanicama adsorbiran na aluminijev hidroksid, hidratizirani
English: 20 micrograms
Croatian: 0,05 miligrama
English: 1 pre-filled syringe +
Croatian: 1 napunjena štrcaljka + 1 igla
English: Hepatitis B surface antigen3,4
Croatian: 720 ELISA jedinica površinski antigen virusa hepatitisa B
English: (Invented) name Strength Pharmaceutical form Route of administration
Croatian: Farmaceutski oblik Put primjene Primarno pakiranje
English: The tablets should be swallowed with water.
Croatian: Tablete se trebaju progutati s vodom.
English: Glustin pioglitazone
Croatian: Glustin pioglitazon
English: The full EPAR for Glustin can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjeloviti EPAR za lijek Glustin nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: It is available as tablets (15, 30 and 45 mg).
Croatian: Dostupan je u obliku tableta (od 15, 30 i 45 mg).
English: This dose may need to be increased after one or two weeks to up to 45 mg once a day if better blood glucose (sugar) control is needed.
Croatian: Tu će dozu možda biti potrebno povećati nakon jednog ili dva tjedna na 45 mg jednom dnevno ako bude potrebna veća kontrola glukoze (šećera) u krvi.
English: The recommended starting dose of Glustin is 15 or 30 mg once a day.
Croatian: Preporučena početna doza lijeka Glustin je 15 ili 30 mg jednom dnevno.
English: Other information about Glustin:
Croatian: Ostale informacije o lijeku Glustin:
English: Further studies also looked at long-term use of Glustin.
Croatian: U daljnjim se ispitivanjima također proučavala dugotrajna uporaba lijeka Glustin.
English: What measures are being taken to ensure the safe and effective use of Glustin?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Glustin?
English: It is used in addition to diet and exercise as follows:
Croatian: Koristi se kao dodatak prehrani i tjelovježbi u sljedećim slučajevima:
English: This is a summary of the European public assessment report (EPAR) for Glustin.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Glustin.
English: It must also not be used in patients who have or have had bladder cancer or those with blood in the urine that has not yet been investigated.
Croatian: Ne smije se također primjenjivati u bolesnika koji imaju ili su imali rak mjehura ili u bolesnika koji imaju krv u mokraći koja još nije ispitana.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Glustin on 11 October 2000.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet za lijek Glustin koje na snazi u Europskoj uniji od 11. listopada 2000.
English: As a consequence, the blood glucose levels are reduced and this helps to control type 2 diabetes.
Croatian: Kao rezultat toga, snižava se razina glukoze u krvi, što pomaže pri kontroli dijabetesa tipa 2.
English: Glustin is a medicine that contains the active substance pioglitazone.
Croatian: Glustin je lijek koji sadrži djelatnu tvar pioglitazon.
English: For more information about treatment with Glustin, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Glustin pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svojem liječniku ili ljekarniku.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Glustin.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet te preporuke o uvjetima za primjenu lijeka Glustin.